To confirm the purity of isolated platelets, the surface expression of the platelet marker CD61 was determined using a specific antibody. Briefly, 1×107 washed platelets were incubated with anti-CD61 monoclonal antibody (GTX61848, Genetex, Irvine, CA, USA) in 0.01% NaN3 and 1% BSA containing Tyrode’s buffer at 4°C for 1 h, followed by Alexa 594-conjugated goat anti-rabbit IgG secondary antibody (1:500; Thermo Fisher Scientific) incubation for another 30 min.
P-selectin (CD62P) surface expression was determined using FITC-conjugated anti-human CD62P (BD Bioscience, San Diego, CA). Platelets (1×107) were incubated with FITC-conjugated anti-human CD62P (1:10) or FITC-conjugated isotype-matched antibodies (BD Bioscience). PS exposure was detected by staining with a fluorescent conjugate of Annexin V, a protein that has a high affinity for PS, using an Alexa Fluor 594 Annexin V/Dead Cell Apoptosis Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions.
To quantify the binding of NS1 on platelet surfaces, a quantity of 1×107 washed platelets was preincubated with or without an anti-TLR4 antibody (5 μg/ml, Genetex) in 0.1% NaN3 and 1 μM PGE1 containing Tyrode’s buffer at 4°C for 1 h. NS1 (5 μg/ml) and FITC-conjugated anti-NS1 monoclonal antibodies (33D2-FITC) were added and then incubated at 4°C for another 3 h. The percent fluorescence signal on the platelet surface was analyzed by FACSCalibur flow cytometry. Data were analyzed using FlowJo software (Tree Star, Ashland, OR, USA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.